<DOC>
	<DOCNO>NCT03095963</DOCNO>
	<brief_summary>A prospective , randomize , single-blind , control , investigator-started clinical trial carry . Patients primary hypothyroidism randomly assign study ( VSL # 3®+ LT4 ) control group ( LT4 ) . A two month treatment phase follow two month follow-up . Clinical examination , blood test thyroid function peripheral tissue marker thyroid hormone effect perform monthly 4 month . LT4 dose adjustment perform study necessary .</brief_summary>
	<brief_title>Interaction Between Levothyroxine Probiotics Hypothyroid Patients</brief_title>
	<detailed_description>Consecutive patient LT4 replacement therapy attend Endocrinology Unit Modena ( Italy ) screen . According inclusion exclusion criterion , eighty participant enrol randomized study control group . The random allocation sequence generate use 'Statistical Package Social Sciences ' software Macintosh ( SPSS ) consider 1:1 ratio statistician Unit . Clinicians evaluate enrol patient blind randomization list . The study design provide monthly visit 4 month overall time-frame . Patients assign study group take probiotic supplement VSL # 3® two month , follow two month period follow-up . Study group patient teach assume probiotic supplement least two hour LT4 administration , dissolve cold beverage store refrigerator ( 2°-8°C ) order preserve bacteria load . The study design single-blind since clinician aware allocation . The VSL # 3® administration provide nurse . Participants invite return use unused sachet count number open sachet per number treatment day . All patient underwent five visit ( baseline , visit 1 , 2 , 3 4 ) anthropometrical evaluation ( weight height ) hormonal function assessment perform . A blood sample take morning visit , empty stomach LT4 ingestion . In occurrence hormonal alteration , LT4 daily dose adjust accord clinical guideline . At baseline , visit 2 visit 4 , patient underwent clinical examination heart rate blood pressure evaluation . During visit , follow data collect : probiotic assumption , sex , age , hypothyroidism aetiology , LT4 formulation dose brand , body mass index ( BMI ) , body surface area ( BSA ) , systolic blood pressure , diastolic blood pressure , heart rate , TSH , fT4 , fT3 possible LT4 posology adjustment . All clinical data databased .</detailed_description>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>primary hypothyroidism LT4 replacement therapy TSH , fT3 fT4 normal range stable LT4 dosage previous six month enrolment Caucasian ethnicity total thyroidectomy thyroid carcinoma high fiber diet intestinal malabsorption ( e.g . bariatric surgery , inflammatory bowel disease , coeliac disease ) ongoing therapy interfere LT4 absorption and/or metabolism ( i.e . aluminiumcontaining antacid , sucralfate , proton pump inhibitor , calcium carbonate , raloxifene , bile acid sequestrants ferrous sulfate ) antibiotic treatment previous six month enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>